Translational Science Committee

The Translational Science Committee covers the process of turning gene and cell therapy observations in the laboratory, clinic, and community into even better interventions that improve the health of patients. We focus on the two most critical junction points in the discovery and development of new gene or cell therapies: translating initial scientific discoveries from academia to industry and advancing preclinical programs to the clinic and through subsequent registration. Each stage builds upon and informs the other. We support and recommend topics covering all stages of this progression, including the process of applying discoveries generated in preclinical laboratory research to experimental studies in animals and human participants, as well as technology innovations and regulatory strategies for investigators to extend often limited clinical observations from early trials into approved drugs.